A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
Recruiting · NCT06843967 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Well Differentiated Liposarcoma, liposarcoma, myxoid liposarcoma, neoplasm, sarcoma | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT06843967 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | United States | 46 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | United States | 184 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) | Commack | United States | 4 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | United States | 186 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | United States | 120 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | United States | 166 |